These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21212411)

  • 1. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.
    Frank NY; Schatton T; Kim S; Zhan Q; Wilson BJ; Ma J; Saab KR; Osherov V; Widlund HR; Gasser M; Waaga-Gasser AM; Kupper TS; Murphy GF; Frank MH
    Cancer Res; 2011 Feb; 71(4):1474-85. PubMed ID: 21212411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cells initiating human melanomas.
    Schatton T; Murphy GF; Frank NY; Yamaura K; Waaga-Gasser AM; Gasser M; Zhan Q; Jordan S; Duncan LM; Weishaupt C; Fuhlbrigge RC; Kupper TS; Sayegh MH; Frank MH
    Nature; 2008 Jan; 451(7176):345-9. PubMed ID: 18202660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
    Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
    Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.
    Lai CY; Schwartz BE; Hsu MY
    Cancer Res; 2012 Oct; 72(19):5111-8. PubMed ID: 22865455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma.
    Schnegg CI; Yang MH; Ghosh SK; Hsu MY
    Cancer Res; 2015 Apr; 75(8):1682-90. PubMed ID: 25769726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of T-cell activation by malignant melanoma initiating cells.
    Schatton T; Schütte U; Frank NY; Zhan Q; Hoerning A; Robles SC; Zhou J; Hodi FS; Spagnoli GC; Murphy GF; Frank MH
    Cancer Res; 2010 Jan; 70(2):697-708. PubMed ID: 20068175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.
    Orecchia P; Conte R; Balza E; Pietra G; Mingari MC; Carnemolla B
    Oncotarget; 2015 Nov; 6(35):37426-42. PubMed ID: 26460958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo.
    Linley AJ; Mathieu MG; Miles AK; Rees RC; McArdle SE; Regad T
    J Biol Chem; 2012 Apr; 287(17):13633-43. PubMed ID: 22393060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit.
    Wilson BJ; Saab KR; Ma J; Schatton T; Pütz P; Zhan Q; Murphy GF; Gasser M; Waaga-Gasser AM; Frank NY; Frank MH
    Cancer Res; 2014 Aug; 74(15):4196-207. PubMed ID: 24934811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells.
    Liu ZJ; Zhou YJ; Ding RL; Xie F; Fu SZ; Wu JB; Yang LL; Wen QL
    PLoS One; 2018; 13(7):e0200845. PubMed ID: 30052652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma chemotherapy leads to the selection of ABCB5-expressing cells.
    Chartrain M; Riond J; Stennevin A; Vandenberghe I; Gomes B; Lamant L; Meyer N; Gairin JE; Guilbaud N; Annereau JP
    PLoS One; 2012; 7(5):e36762. PubMed ID: 22675422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
    Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
    J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma.
    Setia N; Abbas O; Sousa Y; Garb JL; Mahalingam M
    Mod Pathol; 2012 Aug; 25(8):1169-75. PubMed ID: 22555176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGFR1 and PKCα signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner.
    Vartanian A; Stepanova E; Grigorieva I; Solomko E; Baryshnikov A; Lichinitser M
    Melanoma Res; 2011 Apr; 21(2):91-8. PubMed ID: 21389833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCB5 promotes melanoma metastasis through enhancing NF-κB p65 protein stability.
    Wang S; Tang L; Lin J; Shen Z; Yao Y; Wang W; Tao S; Gu C; Ma J; Xie Y; Liu Y
    Biochem Biophys Res Commun; 2017 Oct; 492(1):18-26. PubMed ID: 28821433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
    Wu HB; Yang S; Weng HY; Chen Q; Zhao XL; Fu WJ; Niu Q; Ping YF; Wang JM; Zhang X; Yao XH; Bian XW
    Autophagy; 2017 Sep; 13(9):1528-1542. PubMed ID: 28812437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor initiation in human malignant melanoma and potential cancer therapies.
    Ma J; Frank MH
    Anticancer Agents Med Chem; 2010 Feb; 10(2):131-6. PubMed ID: 20184545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Cell-Surface Marker ABCB5 Causes Characteristic Modifications of Glucose, Amino Acid and Phospholipid Metabolism in the G3361 Melanoma-Initiating Cell Line.
    Lutz NW; Banerjee P; Wilson BJ; Ma J; Cozzone PJ; Frank MH
    PLoS One; 2016; 11(8):e0161803. PubMed ID: 27560924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma spheroid formation involves laminin-associated vasculogenic mimicry.
    Larson AR; Lee CW; Lezcano C; Zhan Q; Huang J; Fischer AH; Murphy GF
    Am J Pathol; 2014 Jan; 184(1):71-8. PubMed ID: 24332013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
    Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
    Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.